Berberine is an insulin secretagogue targeting the KCNH6 potassium channel
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Berberine is an insulin secretagogue targeting the KCNH6 potassium channel
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-23
DOI
10.1038/s41467-021-25952-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A potent antiarrhythmic drug N-methyl berbamine extends the action potential through inhibiting both calcium and potassium currents
- (2020) Huiyuan Hu et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Melanophilin Accelerates Insulin Granule Fusion Without Predocking to the Plasma Membrane
- (2020) Hao Wang et al. DIABETES
- Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
- (2019) Stephanie A Amiel et al. Lancet Diabetes & Endocrinology
- PTC-bearing mRNA elicits a genetic compensation response via Upf3a and COMPASS components
- (2019) Zhipeng Ma et al. NATURE
- Genetic compensation triggered by mutant mRNA degradation
- (2019) Mohamed A. El-Brolosy et al. NATURE
- Coixol amplifies glucose-stimulated insulin secretion via cAMP mediated signaling pathway
- (2019) Abdul Hameed et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
- (2019) Marc Foretz et al. Nature Reviews Endocrinology
- Liraglutide ameliorates palmitate-induced oxidative injury in islet microvascular endothelial cells through GLP-1 receptor/PKA and GTPCH1/eNOS signaling pathways
- (2019) Yunyi Le et al. PEPTIDES
- Insulin secretory effect of sitagliptin: assessment with a hyperglycemic clamp combined with a meal challenge
- (2018) Sudha S. Shankar et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Berberine inhibits glucose oxidation and insulin secretion in rat islets
- (2018) Mengyao Bai et al. ENDOCRINE JOURNAL
- Gliclazide, a K ATP channel blocker, inhibits vascular smooth muscle cell proliferation through the CaMKKβ–AMPK pathway
- (2018) Kyung Young Lee et al. VASCULAR PHARMACOLOGY
- Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects
- (2018) Guofei Li et al. Drug Design Development and Therapy
- From Hyper- to Hypoinsulinemia and Diabetes: Effect of KCNH6 on Insulin Secretion
- (2018) Jin-Kui Yang et al. Cell Reports
- Protective role of berberine and Coptischinensis extract on T2MD rats and associated islet Rin-5f cells
- (2017) Yu-Yu Jiang et al. Molecular Medicine Reports
- Inhibitory effects and mechanism of dihydroberberine on hERG channels expressed in HEK293 cells
- (2017) Dahai Yu et al. PLoS One
- Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects
- (2016) Roy Eldor et al. DIABETES CARE
- Inhibition of voltage-gated potassium channels mediates uncarboxylated osteocalcin-regulated insulin secretion in rat pancreatic β cells
- (2016) Jingying Gao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Natural Products as Sources of New Drugs from 1981 to 2014
- (2016) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Berberine induces pacemaker potential inhibition via cGMP-dependent ATP-sensitive K+ channels by stimulating mu/delta opioid receptors in cultured interstitial cells of Cajal from mouse small intestine
- (2016) Hyun Jung Kim et al. Molecular Medicine Reports
- Metabolomics Study of Type 2 Diabetes Mellitus and the AntiDiabetic Effect of Berberine in Zucker Diabetic Fatty Rats Using Uplc-ESI-Hdms
- (2016) Yu Dong et al. PHYTOTHERAPY RESEARCH
- Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese
- (2016) Raphael N. Alolga et al. Scientific Reports
- Minimizing Hypoglycemia in Diabetes
- (2015) DIABETES CARE
- Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
- (2015) Jiarong Lan et al. JOURNAL OF ETHNOPHARMACOLOGY
- Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets
- (2014) Limei Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
- GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
- (2014) D. Beiroa et al. DIABETES
- High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients
- (2014) Anette P. Gjesing et al. DIABETOLOGIA
- The protective effect of berberine on β-cell lipoapoptosis
- (2014) N. Gao et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Berberine attenuates spontaneous action potentials in sinoatrial node cells and the currents of human HCN4 channels expressed in Xenopus laevis oocytes
- (2014) HUI CHEN et al. Molecular Medicine Reports
- Glucose-induced electrical activities and insulin secretion in pancreatic islet β-cells are modulated by CFTR
- (2014) Jing Hui Guo et al. Nature Communications
- Block of Kv1.7 potassium currents increases glucose-stimulated insulin secretion
- (2012) Rocio K. Finol-Urdaneta et al. EMBO Molecular Medicine
- Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis
- (2012) Hui Dong et al. Evidence-based Complementary and Alternative Medicine
- Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations
- (2011) R. R. Kapoor et al. DIABETOLOGIA
- Activation of AMPK by berberine promotes adiponectin multimerization in 3T3-L1 adipocytes
- (2011) Yun Li et al. FEBS LETTERS
- Loss of Granuphilin and Loss of Syntaxin-1A Cause Differential Effects on Insulin Granule Docking and Fusion
- (2011) Hao Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine
- (2011) Youyou Tu NATURE MEDICINE
- A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse
- (2010) A. Hugill et al. DIABETOLOGIA
- Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research
- (2010) Minzhong Ye et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- Modulation of glucagon-like peptide-1 release by berberine: In vivo and in vitro studies
- (2009) Yunli Yu et al. BIOCHEMICAL PHARMACOLOGY
- Pioglitazone Acutely Reduces Insulin Secretion and Causes Metabolic Deceleration of the Pancreatic β-Cell at Submaximal Glucose Concentrations
- (2009) Julien Lamontagne et al. ENDOCRINOLOGY
- Regulation of voltage-gated K+channels by glucose metabolism in pancreatic β-cells
- (2009) Masashi Yoshida et al. FEBS LETTERS
- Huang-Lian-Jie-Du-Decoction modulates glucagon-like peptide-1 secretion in diabetic rats
- (2009) Yun-Li Yu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation
- (2009) Teresa C Vieira et al. PEDIATRIC DIABETES
- Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I: A Mechanism for the Action of Berberine to Activate AMP-Activated Protein Kinase and Improve Insulin Action
- (2008) N. Turner et al. DIABETES
- Glibenclamide activates translation in rat pancreatic beta cells through calcium-dependent mTOR, PKA and MEK signalling pathways
- (2008) Q. Wang et al. DIABETOLOGIA
- Berberine Acutely Inhibits Insulin Secretion from β-Cells through 3′,5′-Cyclic Adenosine 5′-Monophosphate Signaling Pathway
- (2008) Libin Zhou et al. ENDOCRINOLOGY
- Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
- (2008) Yifei Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Berberine promotes glucagon-like peptide-1 (7–36) amide secretion in streptozotocin-induced diabetic rats
- (2008) Shou-Si Lu et al. JOURNAL OF ENDOCRINOLOGY
- Efficacy of berberine in patients with type 2 diabetes mellitus
- (2008) Jun Yin et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity
- (2008) Zhi-Quan Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now